stockrow
Friday 6 November 2026
Export ATEC’s income statement to Excel — free account
Alphatec Holdings, Inc.
ATEC Healthcare Medical Devices
Alphatec Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $764.2 million, up 25.0% from fiscal 2024.
- Revenue
- +12.6%
- EPS
- +81.7%
- Free cash flow
- −149.2%
- Total debt
- −2.27%
Quarter to September 2026, against a year earlier
7.45
0.35
−4.49%
Follow ATEC
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
| (1,888.01%) | (1,879.90%) | 274.65% | 16,450.51% |
+8 more TTM periods Free account |
|
Piotroski F-Score |
6 | 6 | 6 | 6 | |
| (10.97%) | (13.91%) | (15.82%) | (18.30%) | ||
ROIC |
(4.04%) | (8.10%) | (10.41%) | (12.29%) | |
Return on Tangible Assets |
(22.50%) | (31.40%) | (35.41%) | (39.06%) | |
Average Days of Receivables |
48.16 | 49.32 | 49.33 | 46.48 | |
Free Cash Flow per Share |
(0.07) | (0.04) | (0.01) | (0.03) | |
Free Cash Flow |
(10.44) | (5.74) | (0.78) | (4.41) | |
Capital Expenditures |
(71.78) | (62.26) | (52.34) | (49.64) | |
| Other line items | |||||
Cash ROIC |
(1.67%) | (0.93%) | (0.12%) | (0.60%) | |
Accounts Receivable Turnover |
8.09 | 7.91 | 8.04 | 8.48 | |
Accounts Payable Turnover |
5.21 | 4.62 | 5.89 | 5.27 | |
Inventory Turnover |
1.37 | 1.39 | 1.40 | 1.44 | |
Average Days of Payables |
87.70 | 89.69 | 67.28 | 60.35 | |
Days of Inventory on Hand |
294.42 | 281.44 | 271.84 | 250.06 | |
Tax Rate |
(0.02) | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
9.11% | 9.46% | 9.81% | 9.98% | |
Selling, General and Administrative Expense of Revenue |
63.39% | 64.30% | 64.61% | 65.24% | |
Share Based Compensation of Revenue |
8.95% | 9.52% | 9.54% | 9.65% | |
Interest Coverage |
(0.65) | (1.02) | (1.21) | (1.79) | |
Operating CF/Net income |
(0.71) | (0.51) | (0.41) | (0.32) | |
Depreciation/Fixed assets |
0.80 | 0.80 | 0.79 | 0.78 | |
Capex/Depreciation |
(0.64) | (0.56) | (0.48) | (0.47) | |
Revenue per Share |
5.34 | 5.21 | 5.11 | 5.09 | |
Operating CF per Share |
0.39 | 0.36 | 0.33 | 0.30 | |
Capex per Share |
(0.46) | (0.40) | (0.34) | (0.33) | |
Capex to Sales |
0.09 | 0.08 | 0.07 | 0.07 |
Columns are period end dates · fundamentals updated 6 Nov 2026